SCHEMBL4463860

SCHEMBL4463860

COC(=O)/C=C/c1cc2ccccc2cc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 3/20 0.51
HPGD P15428 2/20 0.51
CCNC P24863 1/20 0.50
CDK8 P49336 1/20 0.50
KMT2A Q03164 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MAPT P10636 3/20 0.48
MEN1 O00255 1/20 0.48
TP53 P04637 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
ALOX15 P16050 1/20 0.48
CYP2C19 P33261 1/20 0.48
HSD17B10 Q99714 1/20 0.48
IDO1 P14902 1/20 0.44
CDC25B P30305 2/20 0.43
GFER P55789 1/20 0.43
NGLY1 Q96IV0 1/20 0.43
TRPA1 O75762 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4463865 1.00 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDCCNCCDK8
SCHEMBL4472635 0.88 CCNC (0.50) ALDH1A1KDM4EHPGDCCNCCDK8
SCHEMBL4472628 0.88 CCNC (0.50) ALDH1A1KDM4EHPGDCCNCCDK8
SCHEMBL15476992 0.82 CA1 (0.50) ALDH1A1KDM4EHPGDCCNCCDK8
SCHEMBL15476991 0.82 CA1 (0.50) ALDH1A1KDM4EHPGDCCNCCDK8
SCHEMBL6799880 0.81 TRPA1 (0.52) ALDH1A1KDM4EHPGDKMT2AMAPT
SCHEMBL6799876 0.81 TRPA1 (0.52) ALDH1A1KDM4EHPGDKMT2AMAPT
SCHEMBL7071660 0.77 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL7071396 0.77 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL69522 0.76 ALDH1A1 (0.58) ALDH1A1KDM4EHPGDCCNCCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572805-B2 Pyrrolo(oxo)isoquinolines as 5HT ligands BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-11 US disclosed
EP-1778225-A2 PYRROLO(OXO)ISOQUINOLINES AS 5HT LIGANDS Bristol-Myers Squibb Company (US) 2007-05-02 EP disclosed
WO-2006019886-A2 PYRROLO(OXO)ISOQUINOLINES AS 5HT LIGANDS BRISTOL-MYERS SQUIBB COMPANY (US) 2006-02-23 WO disclosed
US-20060014777-A1 Pyrrolo(oxo)isoquinolines as 5HT ligands BRISTOL-MYERS SQUIBB COMPANY 2006-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014777-A1 Pyrrolo(oxo)isoquinolines as 5HT ligands HTR2B, OPRD1, HTR1B ALDH1A1 2732/4885KDM4E 2789/4885HPGD 2536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.